Pub. Date : 2019 Nov
PMID : 31441502
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Potential second line treatments are also available when UDCA alone is not effective enough: the farnesoid X receptor (FXR) agonist obeticholic acid, conditionally approved by North American (FDA) and European (EMA) authorities as second line treatment in PBC, or the nonspecific peroxisomal proliferator-associated receptor (PPAR) agonist bezafibrate. | obeticholic acid | peroxisome proliferator activated receptor alpha | Homo sapiens |
| 2 | Potential second line treatments are also available when UDCA alone is not effective enough: the farnesoid X receptor (FXR) agonist obeticholic acid, conditionally approved by North American (FDA) and European (EMA) authorities as second line treatment in PBC, or the nonspecific peroxisomal proliferator-associated receptor (PPAR) agonist bezafibrate. | obeticholic acid | peroxisome proliferator activated receptor alpha | Homo sapiens |